Diverse biological tools DV Biologics offers a broad catalog of human primary, stem, progenitor cells, tissue-derived products, and molecular derivatives, presenting a wide cross-section of research materials that can fuel collaboration with biotech, pharma, and academic partners seeking specialized biological tools.

Extensive disease-focused assets With the industry’s largest assortment of disease-specific samples and IRB-approved donor information, there is a strong upsell opportunity for contract research, custom tissue procurement, and targeted screening studies in oncology, CNS disorders, and neurodegenerative conditions.

HTS and HTS readiness Cell lines suitable for high-throughput and high-content screening across targets such as GPCRs, ion channels, kinases, and enzymes enable collaborations with discovery programs at big pharma and CROs seeking ready-to-use platforms and assays.

Quality and guarantees ISO 9001:2008 certification and a 100% replacement guarantee bolster buyer confidence, making DV Biologics an attractive supplier for regulated procurement pipelines and organizations seeking reliable, auditable sourcing for critical research materials.

Global and academic reach Access to 15 global distributors and a client roster including Pfizer, Genzyme, Amgen, Harvard, Tufts, MGH, and NIH indicates strong credibility and potential for channel partnerships, co-marketing, and targeted outreach to premier academic and biotech institutions.